Supernus Pharmaceuticals reported $158.06M in Trade Debtors for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Aerie Pharmaceuticals AERI:US $ 68.08M 4.46M
Ani Pharmaceuticals ANIP:US $ 150.41M 16.8M
Aurora Cannabis Inc ACB:CN 38.47M 11.64M
Bristol Myers Squibb BMY:US $ 12540M 4029M
Canopy Growth Corp WEED:CN C$ 96.63M 183K
Cara Therapeutics CARA:US $ 9.17M 5.54M
Corcept Therapeutics CORT:US $ 28.16M 0.99M
Eisai 4523:JP Y 198940M 9010M
Eli Lilly And LLY:US $ 7672.4M 133.3M
Endo International Ordinary Shares ENDP:US $ 498.9M 13.24M
Horizon Pharma HZNP:US $ 673.31M 11.2M
JAZZ PHA JAZZ:US $ 594.03M 21.64M
Lannett LCI:US $ 101.21M 0.91M
Marinus Pharmaceuticals MRNS:US 3M 511K
Pacira Pharmaceuticals PCRX:US $ 91.1M 1M
Perrigo Ordinary Shares PRGO:US $ 777.1M 65.3M
Revance Therapeutics RVNC:US $ 5.59M 1.12M
Supernus Pharmaceuticals SUPN:US $ 158.06M 12.91M
Teva Pharmaceutical Industries TEVA:US $ 4471M 218M
United Therapeutics UTHR:US $ 173.4M 2.9M
Xeris Pharmaceuticals Inc XERS:US $ 25.76M 2.37M